Evidence map›Paper›PMID 35175695›Full record

GuidelineRevista medica del Instituto Mexicano del Seguro Social2022

[Integrated Care Protocol: Hypertension].

Gabriela Borrayo-Sánchez, Martin Rosas-Peralta, María Cristina Guerrero-León, Héctor Galván-Oseguera, Adolfo Chávez-Mendoza, Juana Marlen Ruiz-Batalla, Joaquín Vargas-Peñafiel, Virginia Rosario Cortés-Casimiro, Nancy Xochitl Ramírez-Cruz, Carlos Alberto Soto-Chávez and 4 more

Open access · greenAbstract readPractice Guideline
In one paragraph

Guideline in Revista medica del Instituto Mexicano del Seguro Social, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. [Changes in hypertensive control 2020-2021 in a family medicine unit].Revista medica del Instituto Mexicano del Seguro Social · 2024
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Gabriela Borrayo-SánchezInstituto Mexicano del Seguro Social, Dirección de Prestaciones Médicas, Coordinación de innovación en Salud, Programa "A todo Corazón, Código Infarto". Ciudad de México, México.ORCID 0000-0001-8531-9923
Martin Rosas-PeraltaInstituto Mexicano del Seguro Social, Dirección de Prestaciones Médicas, Coordinación de Innovación en Salud, División de Excelencia Clínica. Ciudad de México, México.ORCID 0000-0001-8084-8981
María Cristina Guerrero-LeónInstituto Mexicano del Seguro Social, Hospital de Gineco Obstetricia No. 23 "Ignacio Morones Prieto", Unidad de Cuidados Intensivos Adultos. Nuevo León, México.ORCID 0000-0002-8740-3288
Héctor Galván-OsegueraInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Cardiología, Servicio de Cardiopatías Valvulares, Degenerativas y Congénitas del Adulto. Ciudad de México, México.ORCID 0000-0002-4933-4883
Adolfo Chávez-MendozaInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Cardiología, Clínica de Insuficiencia Cardiaca. Ciudad de México, México.ORCID 0000-0002-1031-3946
Juana Marlen Ruiz-BatallaInstituto Mexicano del Seguro Social, Unidad de Medicina Familiar No. 1, Coordinación de Educación e Investigación en Salud. Ciudad de México, México.ORCID 0000-0003-0793-9910
Joaquín Vargas-PeñafielInstituto Mexicano del Seguro Social, Centro Médico Nacional La Raza. Hospital de Especialidades, División de Cardio Neumo. Ciudad de México, México.ORCID 0000-0003-3697-7764
Virginia Rosario Cortés-CasimiroInstituto Mexicano del Seguro Social, Dirección de Prestaciones Médicas, Coordinación de Innovación en Salud, División de Excelencia Clínica. Ciudad de México, México.ORCID 0000-0001-6793-7314
Nancy Xochitl Ramírez-CruzInstituto Mexicano del Seguro Social, Coordinación de Innovación en Salud. Ciudad de México, México.ORCID 0000-0002-0942-5123
Carlos Alberto Soto-ChávezInstituto Mexicano del Seguro Social, Dirección de Prestaciones Médicas, División de Excelencia Clínica, Área de Evaluación de Programas y Proyectos de Innovación. Ciudad de México, México.ORCID 0000-0002-3842-1906
Juan Luis Gerardo Durán-ArenasUniversidad Nacional Autónoma de México, Facultad de Medicina, Departamento de Salud Pública. Ciudad de México, México.ORCID 0000-0003-4710-9209
Ricardo Avilés-HernándezInstituto Mexicano del Seguro Social, Dirección de Prestaciones Médicas, Unidad de Planeación e Innovación en Salud. Ciudad de México, México.ORCID 0000-0001-8280-4931
Víctor Hugo Borja-AburtoInstituto Mexicano del Seguro Social, Dirección de Prestaciones Médicas, Unidad de Educación e Investigación. Ciudad de México, México.ORCID 0000-0002-7333-5798
Célida Duque-MolinaInstituto Mexicano del Seguro Social, Dirección de Prestaciones Médicas. Ciudad de México, México.ORCID 0000-0002-8252-3205
Mexican Social Security Institute · MXUniversidad Nacional Autónoma de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hypertension is the most common cardiovascular risk factor that is responsible for complications such as cerebrovascular events, heart failure, acute myocardial infarction, kidney failure, arrhythmias and blindness. About 30% of the adult population older than 20 years is a carrier. 40% of carriers are unaware of suffering from it since its onset is generally asymptomatic. Unfortunately, of those who are already known to be hypertensive, only half take drug treatment and of these, only half achieve control figures (<14/90 mmHg). For several decades it has not been possible to forcefully modify the natural history of this disease despite the advancement of therapeutic drugs. The Mexican Institute of Social Security launches the initiative of the Integrated Care Protocols (PAI) of the main diseases. This protocol shows how the three levels of medical care are concatenated, the role of each of the members of the multidisciplinary team for medical care, including: doctor, nurse, social work, psychologist, nutritionist, among others and, to patient sharing. The main changes in diagnostic criteria, in-office and out-of-office blood pressure measurement, drug therapy (monotherapy, dual therapy and triple therapy) and non-drug therapy, and follow-up are presented. The diagnostic-therapeutic approach using algorithm as well as the diagnostic approach to secondary hypertension and special forms of hypertension such as in pregnancy, hypertensive crisis, hypertension in the elderly, ischemic or nephropathy patients.

Indexed as

Delivery of Health Care, IntegratedHypertensionMyocardial InfarctionAdultAgedAntihypertensive AgentsBlood PressureBlood Pressure DeterminationHumansAntihypertensive AgentsDiagnosisHypertensionPreventionTreatment

Identifiers

PMID35175695
PMCPMC10396066
OpenAlexW4226219162

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.